Polygenic Risk Map - Female Complete

Boston Heart’s Polygenic Risk Map test is a genetic test that leverages Polygenic Risk Score (PRS) analysis and reporting. The resulting risk scores provide clinical insights into a variety of important health conditions.

Risk scores are determined by numerous well-studied genetic variations and allow for impactful and targeted application of genomic testing to personalized medicine.

High-risk individuals generally have a substantially increased relative genetic risk for these conditions as compared to low-risk subjects.

Because the lifetime risk of these conditions is also substantially influenced by environment, lifestyle, and medical care, a greater understanding of genetic risks may lead to greater preventive efforts.

Cost-effectiveness studies suggest that providers can reduce cardiovascular events and healthcare system costs by using polygenic risk scores in appropriate patients.

This type of testing is meant to augment rather than replace standard risk factor assessments for cardiovascular disease, breast cancer, prostate cancer or other conditions.

Risk scores provide the lifetime risk of developing the condition of interest.

Analysis included in the Female Complete Polygenic Risk Map:
CAD
Stroke
Atrial Fibrillation
Type 2 Diabetes
Hypertension
BMI
Polygenic Hypercholesterolemia Lipoprotein (a)
Triglycerides
Hypo-HDL Cholesterolemia
Alzheimer's Disease
Breast Cancer
Ovarian Cancer
Brain Cancer
Pancreatic Cancer
Kidney Cancer
Melanoma
Inflammatory Bowel Disease
Early Menopause
Osteoporosis
Psoriasis
Celiac Disease
Ancestry

Avoid the following activities for 30 minutes before collecting your samples.